Exclude genetic anomalies.

Prenatal
Genetics

There are also limits to chromosome analysis:

If, for example, changes occur in very small chromosome segments or only individual genes are altered, this cannot be recognised under the microscope.

  • If the body cells of the unborn child carry a so-called mosaic (a different set of chromosomes), this cannot be recognised with certainty (although this is only very rarely the case)
  • Although we check suspected cases using contamination exclusion, it cannot be ruled out with absolute certainty that maternal cells have grown in the incubator instead of foetal cells (although this occurs in less than 1% of cases)
  • In rare, unfavourable circumstances, the test results for twin pregnancies may only apply to one twin
  • The test result may be available later than usual because the cell cultures grow very slowly (in a few cases)
  • In rare cases, no analysis is possible. In this special case, we will discuss the individual further procedure with you and your gynaecologist. In some circumstances, for example, a repeat puncture may not be necessary if a rapid test has been performed.
Prenatal genetics

Questions or appointments?

Do you have further questions on the subject of "prenatal genetics" or would you like to make an appointment at our practice for prenatal medicine and genetics?

Amniocentesis (amniotic fluid puncture)

For pregnant women or couples who wish to have children, amniocentesis is still the most common test method used today to rule out genetic abnormalities in the unborn child. In this examination, foetal cells are taken from the amniotic fluid and their genetic material is then analysed. In this way, numerous chromosomal disorders can be ruled out with a high degree of certainty. In addition, other diseases or malformations can be ruled out with a high degree of certainty based on the amniotic fluid analysis (e.g. spina bifida aperta, the so-called open back).

Younger pregnant women are also increasingly opting for an amniocentesis if they personally feel that their individual risk (age risk or determined by a first trimester screening) is too high. The decision as to whether an amniocentesis should be carried out can be made by pregnant women or parents-to-be regardless of the individual risk findings for a possible chromosomal disorder in the child.

However, in our practice we only carry out punctures when (at least) the 15th week of pregnancy has ended, as amniocentesis in the first weeks of pregnancy can lead to more frequent complications.

Chorionic villus sampling

The placenta (placenta, chorion in early pregnancy) is derived from the fertilised egg, which is why cells obtained from it can be used to analyse the chromosomes of the child.

If a chromosome analysis is desired or indicated very early in the pregnancy, a chorionic villus sampling makes sense.

In our practice, we perform a chorionic villus sampling from the eleventh week of pregnancy at the earliest. The risk of complications is higher before this, as the embryo's organ development is not yet complete. In contrast to an amniocentesis, a chorionic villus sampling does not provide any information about clefts of the spine (spina bifida aperta).

Umbilical cord puncture

In the case of some diseases of the unborn child, an umbilical cord puncture may be necessary. This procedure allows blood and medication to be introduced into the child's circulation. For diagnostic or therapeutic reasons, this puncture is only possible after the 18th week of pregnancy.

foetal DNA test

During pregnancy, some of the DNA from the foetal part of the placenta passes into the mother's blood. Information about the condition of the baby's chromosomes can be obtained from the DNA. We offer laboratory tests in which the baby's DNA is extracted from a sample of the mother's blood. These are non-invasive prenatal tests (NIPT). This means that these tests are safe for you and your baby. To carry out the test, you must be given a Ultrasound examination only some blood needs to be taken.

The foetal DNA tests can be used to examine the DNA for the risk of the following disorders:

  • Trisomy 21 (Down syndrome)
  • Trisomy 13 (Pätau syndrome)
  • Trisomy 18 (Edwards' syndrome)
  • Monosomy X (Turner syndrome)

More information at FOETAL DNA TESTS.

Array CGH examination

Array CGH analysis is a computer-aided analysis method that can detect the smallest chromosomal changes that were not detected by previous tests. Array CGH analysis is therefore a useful extension and addition to classic chromosome analysis, which can provide new findings in the case of inconspicuous previous genetic findings.

Array CGH analysis can provide reliable information about numerical chromosomal changes within just a few days. In addition, it is also possible to obtain much more precise information about microchanges in the genome using array CGH analysis. Accordingly, array CGH is developing into a very important method of analysis in prenatal diagnostics. Array CGH chip analysis has also become an important method for the examination of physically or mentally impaired children (postnatal examination).

In the case of abnormalities in prenatal diagnostics, the use of an array CGH analysis must currently still be individually authorised by the cost bearers. If there are indications of developmental disorders that cannot be detected using chromosome analysis, array CGH analysis is generally used. In the case of unremarkable findings, the Array-CGH chip analysis can be carried out as an optional service.

Procedure of the Array-CGH examination

For the array CGH test, part of the genetic material (DNA) must be obtained by puncturing the amniotic fluid or umbilical cord or by a chorionic villus sampling. The DNA is then attached to a chip and labelled with fluorescent dyes. This makes it possible to recognise whether certain areas of the unborn child's genome have been lost or contain surplus information.

Prenatal genetics
Prenatal medicine and genetics in Cologne

Ultrasound fine diagnostics

Genetic counselling

Genetic counselling

First trimester diagnostics

First trimester diagnostics

Fetal therapy

Fetal therapy

Prenatal genetics

Prenatal genetics

foetal DNA tests

Foetal DNA tests

Network

Network

Clarification of abnormal findings

Clarification of abnormal findings

late fine diagnostics

Late precision diagnostics

Clarification of abnormal findings | Pre-eclampsia screening

Pre-eclampsia screening

Growth and Doppler control

Growth and Doppler control

Fetal Heart Care

Fetal Heart Care

Menu